Naveen Pemmaraju, Director of Leukemia-Cancer Network, Executive Director of Cancer Medicine, Director of BPDCN at the Department of Leukemia, and Professor at the Department of Leukemia at MD Anderson Cancer Center, shared a post on X:
“Major new paper in the CMML field led by Dr. Guillermo Montalban-Bravo and Dr . Sanam Loghavi just published in Blood Cancer Discovery.”
Title: Incorporation of genomic determinants improves diagnostic accuracy of oligomonocytic chronic myelomonocytic leukemia
Authors: Guillermo Montalban-Bravo, Chong Wu, Juan Jose Rodriguez-Sevilla, Yue Wei, Kelly S. Chien, Ian Bouligny, Rashmi Kanagal-Shamanna, Ziyi Li, Anuya Natu, Mark Gurney, Alexandre Bazinet, Danielle Hammond, Alex Bataller, Gautam Borthakur, Nicholas J. Short, Courtney D. DiNardo, Tapan M. Kadia, Farhad Ravandi, Naval Daver, Naveen Pemmaraju, Elias Jabbour, Ghayas C. Issa, Sa A. Wang, Keyur P. Patel, Guilin Tang, L. Jeffrey Medeiros, Terra L. Lasho, Christy M. Finke, Aref Al-Kali, Clifford M. Csizmar, Hassan Alkhateeb, Naseema Gangat, Abhishek A. Mangaonkar, David Roman-Bravo, Leonor Arenillas, Ayalew Tefferi, Hagop M. Kantarjian, Guillermo Garcia-Manero, Xavier Calvo, Mrinal M. Patnaik, Sanam Loghavi
Read The Full Article
More posts featuring CMML on OncoDaily.